- Chemoimmunotherapy in the treatment of ES-SCLC2021 | First Faculty of Medicine
- Imunooncologic therapeutic options in small cell lung cancer (SCLC) therapy2020 | Faculty of Medicine in Pilsen
- Immunotherapy in the treatment of lung cancer2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Molecular profiling of lung cancer2016 | First Faculty of Medicine
- Pulmonary neuroendocrine tumors2016 | First Faculty of Medicine
- Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC)2010 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trialPublication without faculty affiliation
- Small cell lung cancer - news in the tumour's biology2023 | First Faculty of Medicine, Third Faculty of Medicine
- State of the art and perspectives of Small cell lung cancer treatment2016 | Faculty of Medicine in Pilsen
- Small-cell lung cancer: epidemiology, diagnostics and therapy2017 | Faculty of Medicine in Pilsen
- Small-cell lung carcinoma - news in diagnostics and therapy2016 | Faculty of Medicine in Pilsen
- Major changes in the treatment of small cell lung cancer2023 | Third Faculty of Medicine
- Neuroendocrine tumours2015 | First Faculty of Medicine
- Durvalumab in the treatment of small cell lung cancer2020 | Faculty of Medicine in Pilsen
- News in the treatment of small cell lung cancer2022 | Faculty of Medicine in Pilsen
- Indikace durvalumabu v léčbě pacientů s bronchogenním karcinomem2023 | First Faculty of Medicine
- Topotecan2008 | Publication without faculty affiliation
- Atezolizumab in the treatment of lung cancer2020 | Publication without faculty affiliation
- The methodology and first results of personalized invitation of Czech citizens for cancer screening2015 | First Faculty of Medicine
- Immunotherapy of small cell lung cancer2020 | Publication without faculty affiliation
- Cigarette smoking and lung cancer - relative risk estimates for the major histological types from a pooled analysis of case-control studies2012 | First Faculty of Medicine
- P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens2018 | Faculty of Medicine in Pilsen
- What is the current role of prophylactic cranial irradiation in the treatment algorithm for small cell lung cancer?2023 | Publication without faculty affiliation
- Triple marker composed of p16, CD56, and TTF1 shows higher sesitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens2019 | Faculty of Medicine in Pilsen
- Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer2016 | First Faculty of Medicine
- Actual trends on small cell lung cancer therapy2016 | Faculty of Medicine in Pilsen
- ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas2016 | First Faculty of Medicine
- Video-assisted and robotic-assisted thoracoscopic pulmonary lobectomies, our experience2021 | First Faculty of Medicine
- Perspectives in the treatment of less common mutations in patients with non-small cell lung carcinoma2023 | Publication without faculty affiliation
- Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer2008 | Third Faculty of Medicine